Wall Street expects a year-over-year decline in earnings on lower revenues when Krispy Kreme (DNUT) reports results for the quarter ended March 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 8, 2025, might help the stock move higher if these key numbers are better than expectati ...

Core Viewpoint - The market anticipates a significant year-over-year decline in earnings for Canadian Solar, with a consensus estimate of a quarterly loss of $1.50 per share and revenues expected to drop by 18.1% to $1.09 billion [3][4]. Company Summary - Canadian Solar is projected to report a quarterly loss of $1.50 per share, reflecting a drastic year-over-year change of -889.5% [3]. - The expected revenue for the quarter is $1.09 billion, which is an 18.1% decrease compared to the same quarter last year [3]. - The consensus EPS estimate has been revised down by 164.29% over the last 30 days, indicating a significant reassessment by analysts [4]. - The Most Accurate Estimate for Canadian Solar is higher than the Zacks Consensus Estimate, resulting in a positive Earnings ESP of +13.81% [10][11]. - Despite the positive Earnings ESP, the stock carries a Zacks Rank of 5, complicating predictions of an earnings beat [11]. Industry Summary - SolarEdge Technologies, a competitor in the solar industry, is expected to report earnings per share of $1.20 for the same quarter, indicating a year-over-year increase of +36.8% [17]. - SolarEdge's revenues are projected to be $203.8 million, reflecting a slight decrease of 0.3% from the previous year [17]. - The consensus EPS estimate for SolarEdge has been revised down by 2.5% over the last 30 days, resulting in an Earnings ESP of -8.73% [18].

Eton Pharmaceuticals, Inc. (ETON) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, ...

The market expects Evergy Inc (EVRG) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released o ...

Core Viewpoint - Wall Street anticipates a year-over-year increase in earnings for Expedia, with a focus on how actual results compare to estimates, which could significantly impact stock price [1][2]. Earnings Expectations - Expedia is expected to report quarterly earnings of $0.42 per share, reflecting a year-over-year increase of +100% [3]. - Revenue is projected to be $3.03 billion, representing a 4.8% increase from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 4.85% over the last 30 days, indicating a reassessment by analysts [4]. - A positive Earnings ESP of +14.86% suggests analysts have recently become more optimistic about Expedia's earnings prospects [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that a positive reading is a strong predictor of an earnings beat, especially when combined with a Zacks Rank of 1, 2, or 3 [8]. - Expedia currently holds a Zacks Rank of 3, which, along with the positive Earnings ESP, suggests a likelihood of beating the consensus EPS estimate [11]. Historical Performance - In the last reported quarter, Expedia exceeded the expected earnings of $2.07 per share by delivering $2.39, resulting in a surprise of +15.46% [12]. - Over the past four quarters, Expedia has consistently beaten consensus EPS estimates [13]. Industry Comparison - In the Zacks Internet - Commerce industry, TripAdvisor is expected to report earnings of $0.05 per share, indicating a year-over-year decline of -58.3% [17]. - TripAdvisor's revenue is anticipated to be $389.03 million, down 1.5% from the previous year [17]. - The consensus EPS estimate for TripAdvisor has been revised down by 10% over the last 30 days, resulting in a negative Earnings ESP of -17.24% [18].

The market expects Epam (EPAM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 8, 2025, might help the stock move higher if these key numbers are better than ...

The market expects Granite Ridge Resources, Inc. (GRNT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expect ...

Core Viewpoint - ImmunityBio (IBRX) is anticipated to report a year-over-year increase in earnings driven by higher revenues, with a consensus outlook suggesting a quarterly loss of $0.12 per share, reflecting a 40% improvement from the previous year, and revenues expected to reach $15.69 million, a staggering increase of 39,125% from the same quarter last year [1][3]. Earnings Expectations - The stock price may rise if the actual earnings exceed expectations in the upcoming report, while a miss could lead to a decline [2]. - The consensus EPS estimate has been revised down by 1.45% over the last 30 days, indicating a reassessment by analysts [4]. Earnings Surprise Prediction - The Zacks Earnings ESP model indicates that the Most Accurate Estimate for ImmunityBio is lower than the consensus estimate, resulting in an Earnings ESP of -2.85%, suggesting a bearish outlook [10][11]. - A positive Earnings ESP is generally a strong predictor of an earnings beat, especially when combined with a favorable Zacks Rank [8]. Historical Performance - In the last reported quarter, ImmunityBio was expected to post a loss of $0.26 per share but actually reported a loss of $0.15, resulting in a positive surprise of 42.31% [12]. - Over the past four quarters, the company has beaten consensus EPS estimates twice [13]. Comparative Industry Analysis - Pacira (PCRX), another player in the biomedical and genetics industry, is expected to report earnings of $0.57 per share, reflecting an 8.1% decline year-over-year, with revenues projected at $174.96 million, a 4.7% increase [17]. - Pacira's consensus EPS estimate has remained unchanged over the last 30 days, but it has an Earnings ESP of 34.51%, indicating a strong likelihood of beating the consensus estimate [18].

The market expects Inspired Entertainment (INSE) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 8, 2025, might help the stock move higher if these key number ...

The market expects Insmed (INSM) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended March 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on May 8, 2025, might help the stock move higher if these key numbers are better tha ...